Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases

Obesity

Volumn 23, Issue 9, 2015, Pages 1929-1937

  Xia, Ming Feng ^a   Bian, Hua ^a   Yan, Hong Mei ^a   Lin, Huan Dong ^a   Chang, Xin Xia ^a   Li, Xiao Ming ^a   Ma, Hui ^a   He, Wan Yuan ^a   Zhao, Nai Qing ^a   Xia, Pu ^a   Gao, Xin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY WEIGHT; CHINESE; ECHOGRAPHY; FAT CONTENT; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID COMPOSITION; LIVER FAT CONTENT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; AGED; CHINA; COHORT ANALYSIS; EPIDEMIOLOGY; LIPID METABOLISM; METABOLIC DISEASES; METABOLISM; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAROTID INTIMA-MEDIA THICKNESS; CHINA; COHORT STUDIES; FATTY LIVER; FEMALE; GLUCOSE; HUMANS; LIPID METABOLISM; MALE; METABOLIC DISEASES; MIDDLE AGED; RISK FACTORS;

EID: 84940450401     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21182     Document Type: Article

References (40)

1. Cohen JC, Horton JD, Hobbs HH., Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-1523.
2. Williams R., Global challenges in liver disease. Hepatology 2006; 44: 521-526.
3. Ekstedt M, Franzén LE, Mathiesen UL, et al., Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-873.
4. Angulo P., Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
5. Hamaguchi M, Kojima T, Takeda N, et al., Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13: 1579-1584.
6. Petersen KF, Dufour S, Feng J, et al., Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA 2006; 103: 18273-18277.
7. Kumashiro N, Erion DM, Zhang D, et al., Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 2011; 108: 16381-16385.
8. Magkos F, Su X, Bradley D, et al., Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology 2012; 142: 1444-1446.
9. McPherson S, Jonsson JR, Cowin GJ, et al., Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 2009; 51: 389-397.
10. Kühn JP, Hernando D, Mensel B, et al., Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging 2014; 39: 1494 -1 501.
11. Castera L, Vilgrain V, Angulo P., Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol 2013; 10: 666-675.
12. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ., Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009; 51: 1061-1067.
13. Machado MV, Cortez-Pinto H., Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol 2013; 58: 1007-1019.
14. Sasso M, Beaugrand M, de Ledinghen V, et al., Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36: 1825-1835.
15. de Lédinghen V, Vergniol J, Capdepont M, Chermak F, Hiriart JB, Cassinotto C., Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol 2014; 60: 1026-1031.
16. Xia MF, Yan HM, He WY, et al., Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity (Silver Spring) 2012; 20: 444-452.
17. Gao X, Hofman A, Hu Y, et al., The Shanghai Changfeng study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design. Eur J Epidemiol 2010; 25: 885-893.
18. Li X, Xia M, Ma H, et al., Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: the Shanghai Changfeng study. Atherosclerosis 2012; 224: 480-485.
19. Li X, Xia M, Ma H, et al., Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese. PLoS One 2013; 8: e65210.
20. Nagai Y, Kitagawa K, Sakaguchi M, et al., Significance of earlier carotid atherosclerosis for stroke subtypes. Stroke 2001; 32: 1780 e 5.
21. Wildman RP, Gu D, Reynolds K, Duan X, He J., Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr 2004; 80: 1129-1136.
22. Alberti KG, Zimmet P, Shaw J., Metabolic syndrome: a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-249 7.
24. Yang W, Yang Z, Li G, Xing X., Prediction of metabolic syndrome with combination of waist-to-hip ratio (or waist circumference) and blood pressure measurements. Chin J Endocrinol Metab 2005; 21: 227-229.
25. Yang Y, Qiao J, Li MZ., Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in Chinese population. Reprod Biol Endocrinol 2010; 8: 125.
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D., Modification of diet in renal disease study group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470.
27. Szczepaniak LS, Nurenberg P, Leonard D, et al., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-E468.
28. Wong VW, Chu WC, Wong GL, et al., Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61: 409-415.
29. Fan JG, Peng YD., Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int 2007; 6: 572 -57 8.
30. Fan JG, Farrell GC., Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204 -2 10.
31. Perry RJ, Samuel VT, Petersen KF, Shulman GI., The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014; 510: 84-91.
32. Kumashiro N, Erion DM, Zhang D, et al., Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 2011; 108: 16381-16385.
33. Fan JG, Zhu J, Li XJ, et al., Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005; 43: 508-514.
34. Choi SS, Diehl AM., Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr Opin Lipidol 2008; 19: 295-300.
35. Yamaguchi K, Yang L, McCall S, et al., Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007; 45: 1366-1374.
36. Ducluzeau PH, Boursier J, Bertrais S, et al., MRI measurement of liver fat content predicts the metabolic syndrome. Diabetes Metab 2013; 39: 314-321.
37. Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer JB., Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol 2014; 12: 765-773.
38. Roldan-Valadez E, Favila R, Martínez-Lõpez M, Uribe M, Ríos C, Méndez-Sánchez N., In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: correlation with biochemical method and morphometry. J Hepatol 2010; 53: 732-737.
39. Yan H, Gao X, Liu M, Gu Q, Gao J., Changes of β-cell function and insulin sensitivity in subjects with non-alcoholic fatty liver disease and normal glucose regulation. Chin J Endocrinol Metab 2007; 23: 12-15.
40. Bian H, Lin H, Rao S, et al., Association of liver fat content with insulin resistance and islet β cell function in individuals with various statuses of glucose metabolism. Chin J Endocrinol Metab 2010; 26: 535-540.